NetGenics Expands IBM DiscoveryLink Deal, Readies DiscoveryCenter for Market Launch | GenomeWeb

IBM and NetGenics have expanded their partnership to include an agreement for NetGenics to resell IBM’s DiscoveryLink.

Beth Kleinhenz, vice president of component development at NetGenics, said the expanded agreement is “the next logical step” in a collaboration that began in 1999.

Kleinhenz said that NetGenics has been working actively with IBM to develop a deployment methodology for DiscoveryLink, which was still in prototype form when the partnership began.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.